WASHINGTON – The National Cannabis Roundtable (NCR) released the following statement in response to the Centers for Disease Control’s vaping investigation:
“Health concerns about vaping must be taken seriously and require immediate attention and careful study. As businesses and investors in the legal cannabis industry, all of our members take regulatory compliance as an absolute given and use third party testing to ensure the safety and integrity of their products. A well-regulated cannabis marketplace is the most effective way to police bad actors, and to get counterfeit and tainted products off the market to ensure and protect public health.”